| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |